3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
21
Terminated
8
Recruiting
8
Active not recruiting
5
Withdrawn
1
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
20
Lymphoid
14
Plasma cell
4
Thoracic
3
Other solid neoplasm
3
Genitourinary
3
Gastrointestinal
3
CNS
3
Head & Neck
2
Gynecologic
2
Breast
2
Sarcoma
1
Other neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
hetrombopag
2
treosulfan
1
fludarabine
1
ferric carboxymaltose
1
Vancomycin
1
Therapeutics
1
Teicoplanin
1
Surgical Procedures, Operative
1
S-Adenosylmethionine
1
Rosuvastatin Calcium
1
Rivaroxaban
1
Ofloxacin
1
Observation
1
NF protocol
1
Metronidazole
1
Meropenem
1
Melphalan
1
Levofloxacin
1
Lead
1
Honey
1
Heparin, Low-Molecular-Weight
1
Dalteparin
1
Ciprofloxacin
1
Ceftazidime
1
Cefepime
1
Blood Specimen Collection
1
Aspirin
1
Amikacin
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
fludarabine
×
Classical hematology
×
Clear all
NCT07025824
2025-09-03
RELEVANT
Technische Universität Dresden
Phase 2
Not yet recruiting
220 enrolled